H van Dekken
Overview
Explore the profile of H van Dekken including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
3494
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
van Meerten E, van der Gaast A, Tilanus H, Poley J, Muller K, van Dekken H
J Surg Oncol
. 2009 Apr;
100(1):32-7.
PMID: 19402081
Multimodality treatment is increasingly used in the treatment for esophageal cancer. We determined the tumor regression grade after preoperative chemoradiation and correlated the effect of specific pathologic and clinical findings...
12.
van Heijl M, van Lanschot J, Koppert L, van Berge Henegouwen M, Muller K, Steyerberg E, et al.
BMC Surg
. 2008 Nov;
8:21.
PMID: 19036143
Background: A surgical resection is currently the preferred treatment for esophageal cancer if the tumor is considered to be resectable without evidence of distant metastases (cT1-3 N0-1 M0). A high...
13.
Tran T, van t Hof G, Kazemier G, Hop W, Pek C, van Toorenenbergen A, et al.
Dig Surg
. 2008 Sep;
25(4):311-8.
PMID: 18818498
Background: Obstruction of the pancreatic duct can lead to pancreatic fibrosis. We investigated the correlation between the extent of pancreatic fibrosis and the postoperative exocrine and endocrine pancreatic function. Methods:...
14.
Dost D, van Leerdam M, van Dekken H, Weimar W, Kuipers E, Bijl A, et al.
Gut
. 2008 Aug;
57(9):1330.
PMID: 18719142
No abstract available.
15.
van Dekken H, van Marion R, Vissers K, Hop W, Dinjens W, Tilanus H, et al.
Genes Chromosomes Cancer
. 2008 Apr;
47(8):649-56.
PMID: 18438866
Amplification of chromosome band 7q21 has been frequently detected in various types of cancer including gastroesophageal junction (GEJ) adenocarcinomas. At present, no gene has been disclosed that can explain this...
16.
de Jonge P, Siersema P, Van Breda S, Van Zoest K, Bac D, Leeuwenburgh I, et al.
Aliment Pharmacol Ther
. 2008 Apr;
28(1):127-36.
PMID: 18384663
Background: Chronic oesophageal inflammation and related oxidative stress are important in the pathogenesis of erosive oesophagitis (EO) and its malignant progression. Aim: To study the effect of proton pump inhibitors...
17.
Verhoef C, van Dekken H, Hofland L, Zondervan P, de Wilt J, van Marion R, et al.
Dig Surg
. 2008 Feb;
25(1):21-6.
PMID: 18292657
Background/aim: The evidence on the efficacy of somatostatin analogues in the treatment of hepatocellular carcinoma (HCC) in humans is conflicting. A variety of human tumors demonstrate somatostatin receptors. All subtypes...
18.
van Duin M, van Marion R, Vissers K, Hop W, Dinjens W, Tilanus H, et al.
Cytogenet Genome Res
. 2007 Nov;
118(2-4):130-7.
PMID: 18000363
Amplification of 8q is frequently found in gastroesophageal junction (GEJ) cancer. It is usually detected in high-grade, high-stage GEJ adenocarcinomas. Moreover, it has been implicated in tumor progression in other...
19.
de Jonge P, Wolters L, Steyerberg E, van Dekken H, Kusters J, Kuipers E, et al.
Aliment Pharmacol Ther
. 2007 Jun;
26(1):31-9.
PMID: 17555419
Background: Risk factors for adenocarcinoma of the oesophagus (OAC) and gastric cardia (GCA) are not yet established. Aim: To compare environmental risk factors between patients with OAC and GCA. Methods:...
20.
Kerkhof M, van Dekken H, Steyerberg E, Meijer G, Mulder A, de Bruine A, et al.
Histopathology
. 2007 Jun;
50(7):920-7.
PMID: 17543082
Aims: To determine interobserver variation in grading of dysplasia in Barrett's oesophagus (BO) between non-expert general pathologists and expert gastrointestinal pathologists on the one hand and between expert pathologists on...